High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Huang, Jianfei ^a   Fan, Xiangjun ^a   Wang, Xudong ^a   Lu, Yuhua ^a   Zhu, Huijun ^a   Wang, Wei ^a   Zhang, Shu ^a   Wang, Zhiwei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR2 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; BIOSYNTHESIS; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PANCREAS CARCINOMA; PATHOLOGY; PROGNOSIS; STROMA CELL; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; STROMAL CELLS;

EID: 84939182114     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12991     Document Type: Article

References (45)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29 (2014).
2. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
3. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10-29 (2012).
4. He, C. et al. Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer. Int J Clin Exp Pathol 7, 742-50 (2014).
5. Yu, C. et al. KAP-1 is overexpressed and correlates with increased metastatic ability and tumorigenicity in pancreatic cancer. Med Oncol 31, 25 (2014).
6. Liu, J. H., Chen, G., Dang, Y. W., Li, C. J. & Luo, D. Z. Expression and Prognostic Significance of lncRNA MALAT1 in Pancreatic Cancer Tissues. Asian Pac J Cancer Prev 15, 2971-7 (2014).
7. Zhou, G. et al. Expression of CD44v6 and integrin-beta1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Diagn Pathol 8, 146 (2013).
8. Zhao, G. et al. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One 8, e73803 (2013).
9. Stathis, A. & Moore, M. J. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7, 163-72 (2010).
10. Szkandera, J. et al. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients. PLoS One 8, e78225 (2013).
11. Nakai, Y. et al. A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study. Br J Cancer 106, 1934-9 (2012).
12. Ciliberto, D. et al. Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a metaanalysis of randomised trials. Eur J Cancer 49, 593-603 (2013).
13. Gschwind, A., Fischer, O. M. & Ullrich, A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4, 361-70 (2004).
14. Wright, T. M. & Rathmell, W. K. Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma. J Biol Chem 285, 12916-24 (2010).
15. DeChiara, T. M. et al. Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development. Nat Genet 24, 271-4 (2000).
16. Oishi, I. et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645-54 (2003).
17. Nishita, M. et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 175, 555-62 (2006).
18. Nomachi, A. et al. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 283, 27973-81 (2008).
19. Kobayashi, M. et al. Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107, 398-406 (2009).
20. Suzuki, H. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36, 417-22 (2004).
21. Wright, T. M. et al. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene 28, 2513-23 (2009).
22. Morioka, K. et al. Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 100, 1227-33 (2009).
23. Edris, B. et al. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol 227, 223-33 (2012).
24. Lee, S. E., Lim, S. D., Kang, S. Y., Suh, S. B. & Suh, Y. L. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma. Brain Pathol 23, 445-53 (2013).
25. Guo, M., Liu, W., Serra, S., Asa, S. L. & Ezzat, S. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression. Cancer Res 72, 2017-27 (2012).
26. Qian, Z. et al. High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer. Am J Clin Pathol 141, 226-33 (2014).
27. Chien, A. J., Conrad, W. H. & Moon, R. T. A Wnt survival guide: from flies to human disease. J Invest Dermatol 129, 1614-27 (2009).
28. Stewart, D. J. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 106, djt356 (2014).
29. Arend, R. C., Londono-Joshi, A. I., Straughn, J. M. Jr. & Buchsbaum, D. J. The Wnt/beta-catenin pathway in ovarian cancer: a review. Gynecol Oncol 131, 772-9 (2013).
30. Aguilera, O., Munoz, A., Esteller, M. & Fraga, M. F. Epigenetic alterations of the Wnt/beta-catenin pathway in human disease. Endocr Metab Immune Disord Drug Targets 7, 13-21 (2007).
31. Angers, S. & Moon, R. T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10, 468-77 (2009).
32. Grumolato, L. et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24, 2517-30 (2010).
33. Ford, C. E., Qian Ma, S.S., Quadir, A. & Ward, R. L. The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. Int J Cancer 133, 779-87 (2013).
34. Ren, D., Minami, Y. & Nishita, M. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 16, 304-15 (2011).
35. O'Connell, M. P. et al. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29, 34-44 (2010).
36. Lu, W. et al. The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma. Int J Clin Oncol 19, 1011-9 (2013).
37. Wei, W. et al. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin. Pancreatology 13, 384-92 (2013).
38. Griesmann, H. et al. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Neoplasia 15, 11-22 (2013).
39. Hatta, K. et al. Orphan receptor kinase ROR2 is expressed in the mouse uterus. Placenta 31, 327-33 (2010).
40. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat Med 19, 1423-37 (2013).
41. Kim, G. J. et al. Increased Expression of CCN2, Epithelial Membrane Antigen, and Fibroblast Activation Protein in Hepatocellular Carcinoma with Fibrous Stroma Showing Aggressive Behavior. PLoS One 9, e105094 (2014).
42. Labovsky, V. et al. Association Between Ligands and Receptors Related to the Progression of Early Breast Cancer in Tumor Epithelial and Stromal Cells. Clin Breast Cancer 15, e13-21 (2014).
43. Kasashima, H. et al. Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer. Cancer Lett 354, 438-46 (2014).
44. Sun, R. et al. Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues. Oncotarget 5, 12398-409 (2014).
45. Zhai, X. et al. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Med Oncol 31, 970 (2014).